| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 153, Issue 12 5382-5392, Copyright © 1994 by American Association of Immunologists
ARTICLES |
AG Brooks, PL Campbell, P Reynolds, AM Gautam and J McCluskey
Center for Transfusion Medicine and Immunology, Flinders Medical Center, Bedford Park, Australia.
The behavior of mouse I-Ak molecules was studied in the human Ag presentation mutants T2 and 9.5.3, which contain deleted or mutated HLA DM genes. HLA class II molecules expressed by these APC are defective in presentation of native Ag and are mostly complexed with class II- associated invariant chain peptides (CLIP). In contrast to human class II molecules, a significant proportion of mouse I-Ak molecules expressed in T2 and 9.5.3 were associated with antigenic peptides, indicating that I-Ak/peptide assembly is possible in the absence of the Dm proteins. Thus, the presentation of determinants derived from hen egg lysozyme (HEL), keyhole limpet hemocyanin, and conalbumin was normal in 9.5.3Ak and a conalbumin determinant was presented normally by T2.Ak. However, the keyhole limpet hemocyanin determinant was not presented by T2.Ak, and HEL46-61 was only presented at a low level by these APC. SDS-stable, dimeric I-Ak molecules were expressed by both T2.Ak and 9.5.3Ak and formed late in their intracellular transport. Presentation of HEL46-61 was partially inhibited by disrupting vacuolar acidification in 9.5.3Ak, consistent with I-Ak/peptide assembly in a post-Golgi endosomal compartment. Accordingly, Dm is not an obligatory requirement for MHC class II/peptide assembly. We propose that Dm influences the displacement of CLIP from recently synthesized class II molecules, a process that is likely to be less critical for I-Ak because of its low affinity for CLIP.
This article has been cited by other articles:
|
|
 |
|
  S. B. Lovitch, S. J. Petzold, and E. R. Unanue Cutting Edge: H-2DM Is Responsible for the Large Differences in Presentation Among Peptides Selected by I-Ak During Antigen Processing J. Immunol., September 1, 2003; 171(5): 2183 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Koonce, G. Wutz, E. J. Robertson, A. B. Vogt, H. Kropshofer, and E. K. Bikoff DM Loss in k Haplotype Mice Reveals Isotype-Specific Chaperone Requirements J. Immunol., April 1, 2003; 170(7): 3751 - 3761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Pu, J. A. Carrero, and E. R. Unanue Distinct recognition by two subsets of T cells of an MHC class II-peptide complex PNAS, June 25, 2002; 99(13): 8844 - 8849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Chen, N. Dudek, O. Wijburg, R. Strugnell, L. Brown, G. Deliyannis, D. Jackson, F. Koentgen, T. Gordon, and J. McCluskey A 320-Kilobase Artificial Chromosome Encoding the Human HLA DR3-DQ2 MHC Haplotype Confers HLA Restriction in Transgenic Mice J. Immunol., March 15, 2002; 168(6): 3050 - 3056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Bikoff, G. Wutz, G. A. Kenty, C. H. Koonce, and E. J. Robertson Relaxed DM Requirements During Class II Peptide Loading and CD4+ T Cell Maturation in BALB/c Mice J. Immunol., April 15, 2001; 166(8): 5087 - 5098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-L. Chou and S. Sadegh-Nasseri HLA-DM Recognizes the Flexible Conformation of Major Histocompatibility Complex Class II J. Exp. Med., December 11, 2000; 192(12): 1697 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Felix, W. J. Brickey, R. Griffiths, J. Zhang, L. Van Kaer, T. Coffman, and J. P.-Y. Ting H2-DM{alpha}-/- Mice Show the Importance of Major Histocompatibility Complex-bound Peptide in Cardiac Allograft Rejection J. Exp. Med., June 26, 2000; 192(1): 31 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O'Neil, C. Swanton, A. Jones, P. G. Medd, N. Rayment, and B. Chain IFN-{gamma} Down-Regulates MHC Expression and Antigen Processing in a Human B Cell Line J. Immunol., January 15, 1999; 162(2): 791 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ghumman, E. M. Bertram, and T. H. Watts Chemical Chaperones Enhance Superantigen and Conventional Antigen Presentation by HLA-DM-Deficient as well as HLA-DM-Sufficient Antigen-Presenting Cells and Enhance IgG2a Production In Vivo J. Immunol., October 1, 1998; 161(7): 3262 - 3270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Peterson and A. J. Sant The Inability of the Nonobese Diabetic Class II Molecule to Form Stable Peptide Complexes Does Not Reflect a Failure to Interact Productively with DM J. Immunol., September 15, 1998; 161(6): 2961 - 2967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kenty, W. D. Martin, L. Van Kaer, and E. K. Bikoff MHC Class II Expression in Double Mutant Mice Lacking Invariant Chain and DM Functions J. Immunol., January 15, 1998; 160(2): 606 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Armstrong, V. K. Clements, B. K. Martin, J. P.-Y. Ting, and S. Ostrand-Rosenberg Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity PNAS, June 24, 1997; 94(13): 6886 - 6891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Brooks, P. E. Posch, C. J. Scorzelli, F. Borrego, and J. E. Coligan NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor J. Exp. Med., February 17, 1997; 185(4): 795 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kropshofer, A. B. Vogt, L. J. Stern, and Gün. J. Hämmerling Self-Release of CLIP in Peptide Loading of HLA-DR Molecules Science, November 24, 1995; 270(5240): 1357 - 1359. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
